Barclays
SGFY

Barclays’s Signify Health, Inc. SGFY Stock Holding History

Barclays’s Portfolio SGFY Stock Details SGFY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-25,200
Closed -$734K – 5469
2022
Q3 		$734K Buy
+25,200
New +$580K ﹤0.01% 2443

Other funds holding SGFY

BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
FCA
FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Barclays's SGFY Position: Q1 2023 in Review

Barclays sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 75,143 shares — an estimated $2.15M sold.

Barclays first reported a position in SGFY in Q1 2022 and held it in 4 quarters. The position peaked at $2.69M in Q3 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • Barclays reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Barclays sold 75,143 Signify Health, Inc. shares in Q1 2023, an estimated $2.15M.
  • Barclays first reported a position in Signify Health, Inc. in Q1 2022 and held it in 4 quarters.
  • Barclays's Signify Health, Inc. position peaked at $2.69M in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.